These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17071485)

  • 21. Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome.
    Ewing JC; White JM; Rattray A; Lessells A; Mackie MJ
    Hematology; 2003 Aug; 8(4):211-20. PubMed ID: 12911938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Ann Oncol; 1997; 8 Suppl 2():59-63. PubMed ID: 9209643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.
    McDuffie HH; Pahwa P; Karunanayake CP; Spinelli JJ; Dosman JA
    BMC Cancer; 2009 Feb; 9():70. PubMed ID: 19250521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonrandom occurrence of lymphoid cancer types in 140 families.
    Jones SJ; Voong J; Thomas R; English A; Schuetz J; Slack GW; Graham J; Connors JM; Brooks-Wilson A
    Leuk Lymphoma; 2017 Sep; 58(9):1-10. PubMed ID: 28278712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.
    Kobrinsky NL; Sposto R; Shah NR; Anderson JR; DeLaat C; Morse M; Warkentin P; Gilchrist GS; Cohen MD; Shina D; Meadows AT
    J Clin Oncol; 2001 May; 19(9):2390-6. PubMed ID: 11331317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's disease after treatment of non-Hodgkin's lymphoma.
    Carrato A; Filippa D; Koziner B
    Cancer; 1987 Aug; 60(4):887-96. PubMed ID: 3594408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascertainment and anticipation in family studies.
    Hoh J; Heitjan DF; Mérette C; Ott J
    Hum Hered; 2001; 51(1-2):23-6. PubMed ID: 11096267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
    Jaffe ES; Zarate-Osorno A; Medeiros LJ
    Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas.
    Tavani A; La Vecchia C; Franceschi S; Serraino D; Carbone A
    Eur J Cancer Prev; 2000 Feb; 9(1):59-64. PubMed ID: 10777011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
    Broccia G; Cocco P; Casula P;
    Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticipation in familial Hodgkin's lymphoma.
    Lynch HT
    Hum Genet; 2000 Sep; 107(3):290-3. PubMed ID: 11071392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma of the brain after Hodgkin's disease. An immunohistochemical study.
    Davenport RD; O'Donnell LR; Schnitzer B; McKeever PE
    Cancer; 1991 Jan; 67(2):440-3. PubMed ID: 1985737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
    Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
    Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996.
    van Spronsen DJ; Janssen-Heijnen ML; Breed WP; Coebergh JW
    Ann Hematol; 1999 Jul; 78(7):315-9. PubMed ID: 10466443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.